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Genomic RNA of HIV-1 contains localized structures critical for viral replication. Its
structural analysis has demonstrated a stem-loop structure, SLSA1, in a nearby region
of HIV-1 genomic splicing acceptor 1 (SA1). We have previously shown that the
expression level of vif mRNA is considerably altered by some natural single-nucleotide
variations (nSNVs) clustering in SLSA1 structure. In this study, besides eleven nSNVs
previously identified by us, we totally found nine new nSNVs in the SLSA1-containing
sequence from SA1, splicing donor 2, and through to the start codon of Vif that
significantly affect the vif mRNA level, and designated the sequence SA1D2prox (142
nucleotides for HIV-1 NL4-3). We then examined by extensive variant and mutagenesis
analyses how SA1D2prox sequence and SLSA1 secondary structure are related to
vif mRNA level. While the secondary structure and stability of SLSA1 was largely
changed by nSNVs and artificial mutations introduced to restore the original NL4-3
form from altered ones by nSNVs, no clear association of the two SLSA1 properties
with vif mRNA level was observed. In contrast, when naturally occurring SA1D2prox
sequences that contain multiple nSNVs were examined, we attained significant inverse
correlation between the vif level and SLSA1 stability. These results may suggest that
SA1D2prox sequence adapts over time, and also that the altered SA1D2prox sequence,
SLSA1 stability, and vif level are mutually related. In total, we show here that the entire
SA1D2prox sequence and SLSA1 stability critically contribute to the modulation of vif
mRNA level.
Keywords: HIV-1, SA1, SLSA1, vif mRNA, nNSV, secondary RNA structure, SA1D2prox
INTRODUCTION
RNAs participate in various cellular processes as mRNAs coding proteins and also as non-coding
RNAs involved in regulation of intracellular gene expression, such as micro RNAs and long non-
coding RNAs. Single-stranded RNA molecules contain complex secondary/tertiary structures, such
as hairpins and stem-loops, which are formed by base-paired and -unpaired nucleotides within
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sequences of the molecules. Recent advances in RNA analysis
have revealed that RNA secondary structures of coding and non-
coding RNAs play functional and regulatory roles in various
cellular events (Wan et al., 2011; Bevilacqua et al., 2016; Lu and
Chang, 2016; Silverman et al., 2016).
Structures crucial for viral replication are indeed found in
viral single-stranded RNA genomes like well-known internal
ribosomal entry (Whelan, 2013) and packaging signal (Hunter,
2013) sites. HIV-1 genome justly contains numerous functional
RNA structures required for viral growth, such as Rev-responsive
element, RNA structure involved in gag-pol frameshifting, and
5′ leader of RNA genome including trans-activation element,
splicing donor 1 (SD1, a major donor site), primer binding site,
polyadenylation signal, and packaging signal (Muesing et al.,
1987; Hauber and Cullen, 1988; Berkhout et al., 1989; Dayton
et al., 1989; Olsen et al., 1990; Bartel et al., 1991; Parkin et al.,
1992; Keane et al., 2015; Keane and Summers, 2016). Recently,
HIV-1 RNA (NL4-3) has been clarified for its entire secondary
structure by a chemical-based probing analysis of purified virion
RNA (Watts et al., 2009; Pollom et al., 2013). These studies have
suggested that there may be RNA structures with unidentified
functions in the HIV-1 replication process. In fact, the two
works consistently demonstrated that a region surrounding and
containing the splicing acceptor 1 (SA1) forms a stem-loop
structure, named SLSA1 (Watts et al., 2009; Pollom et al., 2013).
HIV-1 Vif (virion infectivity factor) protein antagonizes
intrinsic retroviral restriction factors, APOBEC3G/F. Thus, the
expression and function of Vif are crucial for HIV-1 replication
in natural target cells such as CD4+-T cells and macrophages
(Kirchhoff, 2010; Blanco-Melo et al., 2012; Harris et al., 2012;
Malim and Bieniasz, 2012). HIV-1 mRNA species are produced
through alternative splicing to express various viral proteins
(Schwartz et al., 1990a,b; Purcell and Martin, 1993; Amendt
et al., 1995). It has been shown that SDs, SAs, and splicing
regulatory elements in viral RNA sequence are involved in
this process (Caputi, 2011; Karn and Stoltzfus, 2012). While
more than 50 transcripts are produced by alternative splicing,
which utilize different combinations of 4 SDs and 10 SAs
(Emery et al., 2017) (Figure 1), vif mRNA is generated
through direct splicing between SD1 and SA1 (Schwartz et al.,
1990a,b; Purcell and Martin, 1993; Amendt et al., 1995).
We have previously demonstrated that vif expression level
is significantly influenced by some naturally occurring single-
nucleotide variations (nSNVs) in the region proximal to SA1
(SA1prox) containing SLSA1, and that most of nSNVs thus
identified were clustered in SLSA1 within SA1prox (Nomaguchi
et al., 2014, 2016). We have also showed that vif expression level
is altered by an nSNV at a splicing regulatory element (GI2-
1) (Widera et al., 2013) just upstream of the Vif start codon
(Nomaguchi et al., 2016). These results raised a possibility that
more nSNVs with effects on vif production may exist around
the SA1prox region, and that SLSA1 structure may participate
in modulation of vif expression. In this study, we identified new
nSNVs that significantly affect vif level within the sequence from
SA1, SD2, and through to the start codon of Vif (designated
SA1D2prox) (Figure 1). We further investigated the SA1D2prox
sequence and SLSA1 secondary structure by extensive functional
and predictive analyses on their variants and mutants to gain
an insight into their virological relevance and significance for
modulation of vif production.
MATERIALS AND METHODS
HIV-1 Sequence Analysis
Nucleotide sequences of SA1D2prox were obtained from the
HIV-1 sequence database (Los Alamos National Laboratory1)
using “subtype B” and “one sequence from one patient” option.
The 2885 sequences of the region corresponding to nucleotides
4891–5040 of pNL4-3 (GenBank accession number AF324493)
(Adachi et al., 1986) were analyzed, excluding sequences
containing mixed nucleotides (N, Y, and R) or insertion/deletion.
Conservation degree among nucleotide sequences of SA1D2prox
was determined by WebLogo3 software2 (Schneider and
Stephens, 1990; Crooks et al., 2004).
Construction of Proviral Clones
Proviral clone pNL4-3 (Adachi et al., 1986) was used as a
parental clone in the present study. A proviral clone that carries
a major consensus sequence of SA1D2prox in HIV-1 subtype
B strains was constructed by introduction of three nSNVs (at
amino acid positions V234Lctt, L241ctt, and I268att in Pol-
integrase) into corresponding sites of pNL4-3, and a resultant
clone was designated pNL-pC3. Based on comparative analysis of
nucleotide sequences of SA1D2prox, one or two of nSNVs at each
amino acid site of Pol-integrase were selected and introduced
into pNL4-3. To generate proviral clones that harbor full-length
viral genomic SA1D2prox sequences, HIV-1 strains were selected
from the HIV-1 compendium 2010-2015 as follows: NL-pSE
(SE600057, GenBank accession number KP411828), NL-p04AR
(B.AR.04.04AR143170, GenBank accession number DQ383750),
NL-p11807 (B.IN.x.11807, GenBank accession number
EF694037), NL-pCu19 (B.CU.99.Cu19, GenBank accession
number AY586542), NL-pDEMB12 (B.JP.12.DEMB12JP001,
GenBank accession number KF716498), NL-pEC003
(B.EC.89.EC003, GenBank accession number AY173959), NL-
pMM45 (B.GB.05.MM45d87_GN1, GenBank accession number
HM586211), NL-p01TT (B.TT.01.01TT_CRC50069, GenBank
accession number EU839608), NL-pCY165 (B.CY.06.CY165,
GenBank accession number FJ388947). These nine clones were
constructed by introducing multiple nSNVs found within viral
genomic SA1D2prox sequences into corresponding sites of
pNL4-3 and pNL-pC3. Introduction of nSNVs into pNL4-3
and pNL-pC3 was carried out using PrimeSTAR Max DNA
polymerase (Takara Bio).
Cells, Transfection, and Virus Replication
Assay
A human embryonic kidney cell line, HEK 293T (Lebkowski
et al., 1985), was cultured in minimal essential medium
supplemented with 10% heat-inactivated fetal bovine serum.
1http://www.hiv.lanl.gov/
2http://weblogo.threeplusone.com/
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FIGURE 1 | Schematic representation of HIV-1 NL4-3 genome. Various splicing donor (SD) and splicing acceptor (SA) sites in HIV-1 genome are indicated. SA4b, a,
c sites are omitted. A blue box indicates SA1D2prox. Black lines represent 4 kb mRNAs of vif and vpr, and exon2 generated by splicing at SA1 and SD2 is indicated
by a gray box. Black arrows and black bars represent amplified regions by qRT-PCR of vif mRNA and all HIV-1 mRNAs, respectively. Regions amplified by
semiquantitative PCR to analyze vpr mRNAs and all HIV-1 mRNAs are shown by red arrows and red bars, respectively.
A human lymphocyte cell line CEM-SS was cultured in
RPMI 1640 supplemented with 10% heat-inactivated fetal
bovine serum. Transfection of proviral clones into 293T cells
were carried out using Lipofectamine 2000 (Thermo Fisher
Scientific) as described previously (Nomaguchi et al., 2014, 2016).
Virion-associated reverse transcriptase activity was measured
as previously described (Willey et al., 1988; Nomaguchi et al.,
2013). Equal units of reverse transcriptase activity (104) were
inoculated into CEM-SS cells (105) for replication analysis
of HIV-1 NL4-3 and its variant clones, and cell culture
supernatants were harvested every 3 days. Virus replication was




293T cells were transfected with proviral clones, and at 20 h
post-transfection, total RNA was isolated by using RNeasy Plus
Mini kit (Qiagen). Total RNA samples were treated with DNase
I (Takara Bio). The nSNVs that affect vif expression level were
screened with QuantiTect probe RT-PCR kit (Qiagen) using
DNase I-treated total RNA as previously described (Nomaguchi
et al., 2016). For analysis of vif mRNA expression, cDNA was
synthesized with Superscript III first-strand synthesis system
(Thermo Fisher Scientific) using DNase-I treated total RNA
samples and an oligo (dT) primer. The cDNA samples were
then subjected to qRT-PCR analysis using Power SYBR Green
Master Mix (Thermo Fisher Scientific). Primer sets used for
qRT-PCR analysis were as follows: NL-U-F and NL-U-R for
all HIV-1 mRNA species (Figure 1) (Nomaguchi et al., 2016),
NL-D1A1 (Exline et al., 2008; Nomaguchi et al., 2016) and
Vif-qPCR (ACCTGCCATCTGTTTTCCATA) for vif mRNA
(Figure 1), Hs-GAPDH-F and Hs-GAPDH-R (Nomaguchi et al.,
2016) for GAPDH mRNA. Linearized pNL4-3, pNL-vif+T, and
pGAPDH+T vectors were used as standards for all HIV-1
mRNA species, vif mRNA, and GAPDH mRNA, respectively,
as described previously (Nomaguchi et al., 2016). Expression
levels of all HIV-1 mRNA species were used for normalization
of transfection efficiency (Nomaguchi et al., 2016).
Semiquantitative PCR Analysis
Semiquantitative PCR analysis was carried out as previously
described using cDNA samples described above (Nomaguchi
et al., 2016). Briefly, PCR products were made by using TaKaRa
LA Taq Hot Start Version (Takara Bio) and a specific primer set
for vpr mRNAs (Figure 1). As controls, all HIV-1 mRNA species
and GAPDH mRNA were amplified using specific primer sets
(Figure 1) (Nomaguchi et al., 2016) in parallel with vpr mRNAs.
PCR products were separated on gels prepared by MetaPhor
agarose (Lonza), and stained with ethidium bromide. Signal
intensities of PCR products were measured by Amersham Imager
600 instrument (GE Healthcare).
SLSA1 RNA Structure Prediction
SLSA1 RNA structures were predicted by the mfold program3
(Zuker, 2003) as described previously (Nomaguchi et al., 2016).
Statistical Analysis
To evaluate the relationship between vif level and SLSA1
structural stability (ddG), scatter diagrams with an exponential
trendline and a coefficient of determination (R2) were generated.
Multiple correlation coefficients obtained by regression analysis
were used to calculate statistical significance of the R2 values
(F-test).
Western Blot Analysis
Proviral clones were transfected into 293T cells, and on day
1 post-transfection, cell lysates were prepared with 1 × TNE
3http://unafold.rna.albany.edu/?q=mfold/RNA-Folding-Form
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buffer (Nomaguchi et al., 2014, 2016). Western blot analysis
was carried out as previously described using anti-Vif [anti-1Q
(Akari et al., 1999), anti-HIV-1 HXB2 Vif (catalog no. 2221; NIH
Research and References Reagent Program) or anti-HIV-1 Vif
319 (catalog no. ab66643; Abcam)] and anti-β-actin clone AC-15
(Sigma–Aldrich) antibodies (Nomaguchi et al., 2014, 2016).
RESULTS
Novel nSNVs That Significantly Alter vif
Expression Level Are Identified within
SA1D2prox Region
We previously showed that some nSNVs, found by comparison
of HIV-1/SIVcpz sequences in SA1prox region (corresponding
to amino acids R224 to P238 of HIV-1 NL4-3 Pol-integrase in
Figure 2), modulate vif expression level and thereby alter viral
replication potential (Nomaguchi et al., 2014, 2016). We also
showed in that study (Nomaguchi et al., 2016) that an nSNV
affecting vif production is present at the splicing regulatory
element GI2-1 (Widera et al., 2013). We here asked whether
such nSNVs still more exist in adjacent to SA1prox (Nomaguchi
et al., 2016). Nucleotide variations were searched for SA1D2prox
region (nucleotides 4899–5040 of HIV-1 NL4-3 in Figures 1, 2)
by aligning sequences of HIV-1 subtype B strains deposited in the
database (Los Alamos National Laboratory4). As seen in Figure 2,
4http://www.hiv.lanl.gov/
while nucleotide sequences are fairly well conserved, there are
a number of sporadic variations. We noted that many of them
are synonymous variations, probably being due to constraints
on the amino acid sequence of Pol-integrase to maintain its
function. Based on this analysis of SA1D2prox, one or two nSNVs
at each codon excluding those in SA1prox were chosen, and
were introduced into an HIV-1 proviral clone NL4-3 (Figure 3).
A variant V234Lctt was also constructed, because Lctt is a major
sequence at the site among HIV-1 subtype B strains (Figure 2).
Thus, a total of 27 proviral clones were newly constructed.
In order to identify new nSNVs in SA1D2prox that alter
vif expression level, we performed qRT-PCR analyses. Proviral
clones constructed were transfected into 293T cells in parallel
with a parental NL4-3 clone. At 20 h post-transfection, DNase
I-treated total RNA samples were prepared and subjected to
qRT-PCR analysis using a specific primer set for vif transcript.
Proviral clones that could affect vif mRNA production were
further analyzed by qRT-PCR with cDNA synthesized using an
oligo (dT) primer and DNase I-treated total RNA as a template.
Predictably, essentially the same results were obtained for levels
of the vif transcript and vif mRNA. As shown in Figure 3, vif
levels by most clones tested were similar or modestly changed
relative to that by NL4-3. Because viral replication potentials
are empirically known not to be substantially influenced by
such small changes (Nomaguchi et al., 2016), we selected six
variants for further analysis, which carry an nSNV (K240aaa,
L242ctt, A248gcg, V249gtg, N254aac, or V259gtg) that exhibit
vif expression levels under 0.5 or over 1.2 relative to NL4-3
FIGURE 2 | Sequence alignment of SA1D2prox among HIV-1 subtype B viruses. Nucleotide sequence logo was created by WebLogo3 software
(http://weblogo.threeplusone.com/create.cgi) (Schneider and Stephens, 1990; Crooks et al., 2004). Sequences (2885 sequences corresponding to nucleotides
4891–5040 of HIV-1 NL4-3) of HIV-1 subtype B were obtained from the HIV-1 sequence database (Los Alamos National Laboratory, http://www.hiv.lanl.gov/). Start
and end positions of SA1D2prox region, SA1 and SD2 sites, the start codon for Vif, and a splicing regulatory element GI2-1 are indicated. Amino acids and their
numbers of NL4-3 Pol-integrase are shown above the sequence. Numbers below the sequence represent nucleotide numbers of HIV-1 NL4-3.
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FIGURE 3 | Effects of nSNVs in SA1D2prox on vif expression. Proviral clones indicated were transfected into 293T cells, and at 20 h post-transfection, total RNAs
were prepared. After DNase I-treatment, samples were subjected to qRT-PCR analysis by a specific primer set for vif transcript (Figure 1). For clones designated
K240aaa, L242ctt, A248gcg, V249gtg, N254aac, and V259gtg, cDNA samples synthesized using DNase I-treated RNA and oligo (dT) primer were subjected to
qRT-PCR analysis. Expression levels of all HIV-1 transcripts/mRNAs and GAPDH transcript/mRNA were analyzed by qRT-PCR in parallel as transfection and internal
controls, respectively. A vif expression level in each sample was normalized by those of all HIV-1 transcript/mRNA species and GAPDH transcript/mRNA. Vif
expression levels relative to that by NL4-3 are presented. Blue letters/bar, red letters/bars, and green letters/bar indicate low, high, and excessive vif types
(Nomaguchi et al., 2016), respectively. Mean values ± SD from four independent experiments are shown.
(colored clones in Figure 3). Expression levels of Vif protein
by these variants fluctuated in a consistent manner with vif
mRNA levels as expected (data not shown) (Nomaguchi et al.,
2016).
We previously showed that proviral clones carrying an nSNV
in SA1prox can be categorized into three types based on their vif
and Vif expression levels, i.e., low, high, and excessive vif types
(Nomaguchi et al., 2016). These types are also distinguished and
characterized by inverse correlation of vif and vpr expression
levels, and by viral growth capacity in the presence and absence
of APOBEC3G (Nomaguchi et al., 2016). To further substantiate
this virological observation, and to classify and characterize newly
constructed six clones (K240aaa, L242ctt, A248gcg, V249gtg,
N254aac, and V259gtg in Figure 3), we first examined effects
of these nSNVs on vpr mRNA production by semiquantitative
PCR analysis as previously described (Nomaguchi et al., 2016).
Proviral clones were transfected into 293T cells in parallel with
control clones [parental clone (NL4-3), low vif type (K236aag),
high vif type (P233cct), and excessive vif type (P238ccg) in
Nomaguchi et al., 2016]. At 20 h post-transfection, cells were
collected and cDNA samples were prepared as described above.
As shown in Figure 4A, these clones tested displayed different
levels of vpr mRNA expression. L242ctt produced vpr mRNA
at a similar level with K236aag and at a higher level than NL4-
3, indicating it belongs to the low vif group. Vpr levels by
the other four (K240aaa, A248gcg, N254aac, and V259gtg) and
one (V249gtg) new clones were similar to those by P233cct
(high vif ) and P238ccg (excessive vif ), respectively. As shown
in Figure 4B, signal intensities of PCR products in four
independent experiments quantitatively confirmed the results
for vpr mRNA expression levels by L242ctt and two variants
(K240aaa and V259gtg) relative to that by NL4-3 in Figure 4A.
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FIGURE 4 | Effects of vif-affecting nSNVs on vpr expression and virus
replication. (A) Vpr expression pattern. Semiquantitative PCR was carried out
using a specific primer set for vpr mRNAs (Figure 1), and cDNA samples were
prepared as described in Figure 3. NL4-3 and K236aag/P233cct/P238ccg
clones were used as a parental clone and as standard control clones for low
(L)/high (H)/excessive (E) vif types (Nomaguchi et al., 2016), respectively.
Expression levels of all HIV-1 mRNA species (exon7) and GAPDH mRNA were
analyzed by semiquantitative PCR in parallel as transfection and internal
controls, respectively. RNA size markers in nucleotides are indicated on the
right. Representative data from four independent experiments are shown.
(B) Quantification of vpr expression level. Signal intensities of semiquantitative
RT-PCR products were quantitated by Amersham Imager 600 instrument.
Intensity of vpr3 mRNA in each sample was normalized by those of all HIV-1
mRNA species (exon 7) and GAPDH mRNA. Normalized mRNA intensity in
each sample relative to that of NL4-3 is presented. Mean values ± SD from
four independent experiments are shown. (C) Viral growth kinetics in CEM-SS
cells. Viruses were prepared from 293T cells transfected with proviral clones
indicated, and equal units of reverse transcriptase activity (104) were
inoculated into CEM-SS cells (105). Virus replication was monitored by reverse
transcriptase activity released into the culture supernatants. The results
shown were reproduced in another independent experiment.
On the other hand, Figure 4B gave the results that require
further experimentation for A248gcg, V249gtg, and N254aac.
Although mean values for vpr expression level for A248gcg and
N254aac were lower than that for NL4-3, statistically significant
difference was not obtained. Another variant V249gtg showed
an intermediate vpr expression level between those by P233cct
(high vif ) and P238ccg (excessive vif ). We therefore examined
the three variant clones (A248gcg, V249gtg, and N254aac) for
their biological consequences by assessing viral growth capacity
in CEM-SS cells with a low APOBEC3G level (Nomaguchi
et al., 2016). In CEM-SS cells, viruses of the high vif type grew
moderately poorly relative to NL4-3, and those of the excessive
vif type propagated further more poorly relative to a virus
of the high vif type (Nomaguchi et al., 2016). Input viruses
were prepared from 293T cells transfected with test (A248gcg,
V249gtg, and N254aac) or control (NL4-3, P233cct, and P238ccg)
clones, and were inoculated into CEM-SS cells. As shown in
Figure 4C, A248gcg and N254aac grew markedly similarly
with P233cct (high vif ), slightly more inefficiently than NL4-3.
Another test clone V249gtg displayed significantly slow growth
kinetics than the others including P238ccg of the excessive
vif type. This experiment was repeated with similar results.
Collectively, based on vif /vpr expression levels and replication
potentials (Figures 3, 4), six new proviral clones were grouped as
low (L242ctt), high (K240aaa, A248gcg, N254aac, and V259gtg),
and excessive (V249gtg) vif type viruses.
The nSNVs That Affect vif Expression
Level Are Widely Distributed in the
SA1D2prox Region and Many of Them
Are Clustered in SLSA1
Several splicing regulatory elements that affect vif mRNA
production and/or usage of SA1 and SD2 sites have been
reported. These elements include, from 5′ to 3′, exonic splicing
enhancer Vif (ESEVif), ESE-M1/M2, G4 motif, exonic splicing
silencer 2b (ESS2b), ESE2b, and GI2-1 (Kammler et al., 2006;
Exline et al., 2008; Mandal et al., 2009; Widera et al., 2013;
Brillen et al., 2017). As presented in Figure 5, we here mapped
twenty nSNVs that alter vif expression level identified by us
so far (results in this study and in Nomaguchi et al., 2016)
to SA1D2prox along with above splicing regulatory elements.
Of these effective nSNVs, 13 increased and 7 decreased vif
expression. While found throughout SA1D2prox, many of the
nSNVs valid for modulation of vif production resided in its 5′
half including SLSA1 (15/20 nSNVs). All vif -decreasing nSNVs
were located at the 5′ half and only vif -increasing nSNVs were
present in the 3′ half. Of note, twelve effective nSNVs were
clustered in SLSA1, suggesting a possible involvement of SLSA1
(sequence and/or structure) in modulation of vif production.
Another important point to be mentioned in Figure 5 is that
six nSNVs (V234gtg, P238ccg, K240aaa, L242ctt, A248gcg, and
V249gtg) are located at distinct sites from elements reported
previously (Kammler et al., 2006; Exline et al., 2008; Mandal
et al., 2009; Widera et al., 2013; Brillen et al., 2017). This
finding suggests a potential existence of novel splicing regulatory
elements so far unidentified. In sum, seventeen codon sites
Frontiers in Microbiology | www.frontiersin.org 6 December 2017 | Volume 8 | Article 2542
fmicb-08-02542 December 14, 2017 Time: 17:47 # 7
Nomaguchi et al. Modulation of vif-mRNA by HIV-1-SA1D2prox
FIGURE 5 | Locations of nSNVs in SA1D2prox sequence (nucleotides 4899-5040 of HIV-1 NL4-3) that significantly alter vif expression level. Numbers below the
sequences represent amino acid positions of HIV-1 NL4-3 Pol-integrase. SA1/SD2 sites and reported splicing regulatory elements (ESEVif, ESE-M1, ESE-M2, G4
motif, ESS2b, ESE2b, and GI2-1 in Kammler et al., 2006; Exline et al., 2008; Mandal et al., 2009; Widera et al., 2013; Brillen et al., 2017) are shown. A blue line
indicates the SLSA1 region. The nSNVs that significantly alter vif expression level are shown by colored and bold letters. Blue/red/green letters indicate
low/high/excessive vif types (Nomaguchi et al., 2016), respectively. Red dots show the sites for which no proviral clones for analysis were constructed, because the
sequences are highly conserved among HIV-1 subtype B strains. Black dots represent the sites for which proviral clones were constructed and analyzed, but nSNVs
there were found to affect vif production only modestly. ψ, G, and T variants are also high vif type. §, C variant is also high vif type.
(twenty nucleotides) in SA1D2prox (142 nucleotides) are found
to be effective for modulation of vif expression level (Figure 5). It
is clear from these results that SA1D2prox is a critical functional
region to modulate vif expression.
Changes in SLSA1 Secondary Structure
and Stability by nSNVs Are Not
Well-Correlated with Those in vif
Expression Level
Accumulating evidence suggests that RNA secondary structures
impact mRNA processing such as the polyadenylation, splicing,
degradation, and translation (Wan et al., 2011; Bevilacqua et al.,
2016; Lu and Chang, 2016; Silverman et al., 2016). Because
many of the nSNVs that significantly affect vif expression level
were localized within SLSA1 (Figure 5), we hypothesized that
SLSA1 sequence and/or structure may contribute to modulation
of vif production. In order to examine relationship between
vif production and SLSA1, we utilized the mfold program
(Zuker, 2003) to predict changes in SLSA1 secondary structure
and free energy (dG) caused by nSNVs in SLSA1. When
multiple structures were expected for an nSNV-bearing SLSA1,
a structure with lowest dG, i.e., the most stabilized structure,
was selected. In fact, a structural shape of HIV-1 SLSA1 RNA
(NL4-3) inferred in this way was highly similar to that solved
by a chemical probing approach (Figure 6) (Pollom et al.,
2013). We then investigated effects of 13 nSNVs in SLSA1
(R224cgc, Y226tac, R228aga, D229gat, R231Kaaa, D232gac,
P233cct/ccc/ccg, V234gtg/gta/gtc, and K236aag in Figure 5) on
vif expression level and RNA shape/stability (Figures 6, 7).
Stability shift by individual nSNVs of SLSA1 secondary structure
was determined by difference from NL4-3 dG as ddG. Nine clones
designated R224cgc, Y226tac, R228aga, D229gat, R231Kaaa,
D232gac, P233cct, V234gtg, and K236aag were previously
analyzed for vif expression and SLSA1 stability (Nomaguchi
et al., 2016). Therefore, to obtain experimental data on vif
production, six clones, i.e., P233cct/ccc/ccg and V234gtg/gta/gtc
were assayed here. Vif expression levels were assessed by qRT-
PCR analysis using cDNA samples and a specific primer set for
vif mRNA. As is clear in Figures 6, 7, most of the nSNV variants
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FIGURE 6 | Changes in SLSA1 RNA secondary structure by nSNVs within SLSA1. Various nSNVs analyzed are indicated by orange-boxed capital letters.
Secondary RNA structure for the SLSA1 sequence carrying an nSNV was predicted by mfold program (Zuker, 2003).
predictively showed different results of the shape and stability
of SLSA1 from those for NL4-3. SLSA1 RNA structure carrying
V234gtc was identical to that of NL4-3 (Figure 6), whereas the
energy of its structure was moderately increased by formation
of a G-C canonical pair instead of a G·U wobble pair (dG is
−7.7 for V234gtc and −5.7 for NL4-3) (Figure 7). Moreover,
V234gtc produced higher level of vif mRNA relative to NL4-3
(∼1.5) (Figure 7). While only R231Kaaa gave the same SLSA1
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FIGURE 7 | Changes in vif expression level and SLSA1 RNA stability by nSNVs within SLSA1. Free energy (dG) for the SLSA1 sequence carrying an nSNV was
predicted by mfold program (Zuker, 2003). RNA stability (ddG) is presented as difference of free energy between each nSNV and NL4-3. For determination of vif
production level, proviral clones indicated were transfected into 293T cells, and at 20 h post-transfection, DNase I-treated total RNAs were prepared. After synthesis
of cDNA using DNase I-treated RNA and oligo (dT) primer, samples were subjected to qRT-PCR analysis using a specific primer set for vif mRNA. Expression levels
of all HIV-1 mRNA species and GAPDH mRNA were analyzed by qRT-PCR in parallel for transfection and internal controls, respectively. A vif expression level in each
sample was normalized by those of all HIV-1 mRNA species and GAPDH mRNA. Vif expression levels relative to that by NL4-3 are presented. Mean values ± SD
from three independent experiments are shown. Scatter diagram on the right was created by plotting vif expression levels and SLSA1 stabilities [–(ddG)] of variant
clones with nSNVs relative to those of NL4-3. Exponential trendline and coefficient of determination (R2 = 0.024, p = 0.549 by F-test) are shown. Blue, red, and
green letters indicate low, high, and excessive vif types (Nomaguchi et al., 2016), respectively. In this figure, the data of relative vif expression levels in our previous
report (Nomaguchi et al., 2016) were used for clones R224cgc, Y226tac, R228aga, D229gat, R231Kaaa, D232gac, and K236aag for easy comparison.
structure (Figure 6) and energy with those of NL4-3 (dG =−5.7)
(Figure 7), its vif expression level was significantly lower than
that of NL4-3 (∼0.36) (Figure 7), indicating the importance
of the nucleotide sequence at this site. To obtain a clue to
quantitative relationship of vif mRNA and SLSA1, relative vif
expression levels and SLSA1 stability values of the 13 variants
were plotted to a scatter diagram using NL4-3 as a standard
(Figure 7). No clear correlation was observed between them
(R2 = 0.024).
Vif Expression Levels Fluctuate
Independently of Changes in SLSA1
Secondary Structure Induced by nSNVs
and Artificial Mutations That Recover the
Original Structural Shape of NL4-3
SLSA1
To further investigate relationship between vif production and
SLSA1 secondary structure, we newly constructed several SLSA1
structural mutants. Since some nSNVs (R224cgc, Y226tac, and
K236aag), located at the stem of NL4-3 SLSA1, exhibited
relatively strong effects on vif expression level and SLSA1 shape
(Figures 6, 7) (Nomaguchi et al., 2016), we generated various
SLSA1 mutants with the NL4-3 structural shape by introduction
of an artificial mutation restoring complementarity of the
stem in combinations with the nSNVs (Figure 8). A mutation
P238Rcga was introduced into R224cgc variant (complementary
sites are underlined) to construct a double mutant designated
R224cgc+P238Rcga. This SLSA1 double mutant was predicted
to have the same SLSA1 shape (dG = −5.2) with that of R224cgc
variant (Figure 9), whereas the NL4-3 shape with a higher energy
(dG = −4.4) was also expected as one of predictable structures.
A mutation K236Raga was introduced into Y226tac variant
to construct a double mutant designated Y226tac+K236Raga.
This double mutant was predicted to form the same SLSA1
structure with that of NL4-3 (Figure 9). For K236aag variant,
two SLSA1 structural mutants were constructed by introducing
two mutations. One was Y226Fttt that forms a G·U wobble base
pair, and the other was Y226Stct that forms a G-C canonical
base pair. While these double mutants (K236aag+Y226Fttt and
K236aag+Y226Stct) were predicted to have the same SLSA1
structural shape with that of NL4-3 (Figure 9), free energies for
the structures were expected to be different owing to formation
of G·U or G-C base pair.
The above variants or mutants (eleven clones in total)
carrying nSNV alone, artificial mutation alone, or double
mutations were analyzed for their vif expression levels and
SLSA1 stabilities. As readily seen in Figure 10, all single
mutants carrying nSNVs (R224cgc, Y226tac, and K236aag)
or artificial mutations (P238Rcga, K236Raga, Y226Fttt, and
Y226Stct) showed significantly altered relative vif levels.
Especially, Y226 mutations (Y226tac, Y226Fttt, and Y226Stct)
highly affected vif production (values relative to NL4-3 level
were 0.05, 4.50, and 3.36, respectively). Y226 site is located
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FIGURE 8 | Secondary RNA structure of HIV-1 NL4-3 SLSA1. Secondary
RNA structure of NL4-3 SLSA1 was predicted by mfold program (Zuker,
2003). In the structure, amino acid sites R224/Y226/K236/P238 of NL4-3
Pol-integrase, the corresponding codons (black-boxed), nucleotide sites
analyzed (orange-boxed), and the complementary mutations (blue-boxed) are
shown. Nucleotide substitutions are also shown by arrows.
at the polypyrimidine tract just upstream of SA1 (Figure 5),
and thus its mutations may markedly influence the splicing
at SA1 through alteration of binding to splicing factors. We
have previously shown that HIV-1 strains carrying multiple
nSNVs in SA1prox exist in infected individuals, and that
such nSNVs exhibit an additive effect on modulation of vif
production (Nomaguchi et al., 2016). We thus suggested that
vif expression level was determined by relative strength of
splicing regulatory sites around SA1 site (Nomaguchi et al., 2016).
In agreement with our previous results, each mutation in the
double mutants (R224cgc+P238Rcga, K236aag+Y226Fttt, and
K236aag+Y226Stct) appeared to separately affect vif production,
resulting in similar expression levels to that by NL4-3 (relative
levels were from 0.90 to 1.31) (Figure 10). These results
FIGURE 9 | Predicted secondary RNA structures of SLSA1 structural
mutants. Secondary RNA structures of the SLSA1 mutants were predicted by
mfold program (Zuker, 2003). In the structures of SLSA1 variants, their nSNVs
analyzed are indicated by orange-boxed capital letters. Complementary
mutations to the nSNVs are indicated by blue-boxed capital letters.
confirmed independent contribution of individual mutations in
SLSA1 to vif production. In contrast, remarkably decreased vif
expression level by Y226tac was not recovered with introduction
of K236Raga into Y226tac (Y226tac+K236Raga), supporting that
Y226tac exhibits a specially potent effect on vif production as
described above. To quantitatively evaluate relationship between
vif production and SLSA1, vif levels relative to that by NL4-
3 and SLSA1 stabilities of the 11 variants/mutants were plotted
to a scatter diagram (Figure 10). Clear correlation was not
observed (R2 = 0.084). In total, changes in SLSA1 structural
shape/stability by mutations were not significantly correlated
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with those in vif expression (Figures 9, 10). This conclusion
was further supported by the data that vif expression levels by
R224cgc and by R224cgc+P238Rcga were considerably different
(approximately threefold difference in vif expression level),
although the secondary structures and stabilities of SLSA1 RNAs
of these two variants were the same each other (Figures 9, 10).
Inverse Correlation between vif
Expression Level and SLSA1 Structural
Stability Is Observed for Proviral Clones
Carrying a Full-Length Viral Genomic
SA1D2prox Sequence Found in the HIV-1
Population
As observed in Figure 2, there are well-conserved and variable
nucleotides in SA1D2prox sequences from HIV-1 subtype B
strains. We have shown so far that HIV-1 strains carrying
multiple nSNVs in SA1D2prox exist in infected humans, and that
each nSNV in the region can independently affect vif production
to a different degree (Figures 2, 3, 7 and Nomaguchi et al., 2016).
Moreover, considering high mutability and adaptability of HIV-
1, it is reasonable to assume that mutations may accumulate in
SA1D2prox to express vif mRNA at a level tolerable for viral
replication under a given environment. To test this assumption,
we first constructed HIV-1 variants carrying a naturally occurring
entire SA1D2prox sequence, and next amply characterized
them for various properties. Finally, relationship between vif
level and SLSA1 stability of variant clones was evaluated by
scatter diagram analysis. For this direction, we selected nine
SA1D2prox sequences from HIV-1 subtype B strains in the HIV-
1 compendium 2010–2015 (Figure 11). The naturally occurring
SA1D2prox sequences were carefully chosen to contain different
combinations of multiple nSNVs that increase or decrease vif
expression level. We thus constructed nine proviral clones
that carry each full-length SA1D2prox sequence from HIV-1
subtype B strains (NL-pSE, NL-p04AR, NL-p11807, NL-pCu19,
NL-pDEMB12, NL-pEC003, NL-pMM45, NL-p01TT, and NL-
pCY165 in Figure 11). In addition, we constructed four proviral
clones carrying an unanalyzed nSNV (V234Lctg, D256Egaa,
D256Egag, and V259Iata) found in the above nine SA1D2prox
sequences. Numerous sequences of subtype B strains in the HIV-
1 compendium indicate that HIV-1 NL4-3 has a minor sequence
in SA1D2prox at Pol-integrase amino acid codons 234, 241, and
268. We therefore constructed a new proviral clone designated
NL-pC3 by introducing three variations (V234Lctt, L241ctt, and
I268att) into NL4-3 as a standard with a consensus sequence in
SA1D2prox.
We then assessed vif expression level of the fourteen test
and control clones newly constructed. As shown in Figure 12A,
vif level by NL-pC3 was modestly low relative to that by
NL4-3, probably due to an effect of I268att (relative level to
NL4-3 was ∼0.7 in Figure 3). No test clones with a naturally
occurring full-length SA1D2prox sequence from different viral
strains significantly increased vif production level relative to
that by NL-pC3. While five out of nine clones (NL-p04AR, NL-
pCu19, NL-pEC003, NL-pMM45, and NL-pCY165) produced
vif mRNA to a similar extent with NL-pC3 (relative levels to
NL-pC3 were from 0.72 to 1.09), the other four clones (NL-
pSE, NL-p11807, NL-pDEMB12, and NL-p01TT) did to a lower
level (relative levels were 0.50, 0.04, 0.30, and 0.36, respectively).
Drastic decrease observed for NL-p11807 could be attributable
to an effect by Y226tac variation as described above (Figures 7,
10). These results may suggest that vif expression level is mainly
determined by some particular nSNV(s) in SA1D2prox, although
the clones examined have multiple nSNVs that enhance or
reduce vif production (Figure 11). Somewhat unexpectedly, no
clones showed an upregulated expression of vif mRNA in the
presence of nSNVs with an enhancing effect in SA1D2prox
(Figure 11). Of proviral clones carrying newly found variations
(V234Lctg, D256Egaa, D256Egag, and V259Iata), only V234Lctg
significantly increased vif expression level (Figure 12A).
Nine proviral clones with a naturally occurring SA1D2prox
sequence (Figure 11) were next examined for their abilities to
express Vif protein and vpr mRNA for confirmation purpose.
As shown in Figure 12B, while five clones (NL-p04AR, NL-
pCu19, NL-pEC003, NL-pMM45, and NL-pCY165) produced Vif
similarly with NL-pC3, NL-p11807 expressed an undetectable
level of Vif, being consistent with the RNA data (Figure 12A).
The other three clones (NL-pSE, NL-pDEMB12, and NL-p01TT)
expressed Vif at a lower level relative to that by NL-pC3,
again being in agreement with the RNA data (Figure 12A).
Expression of vpr mRNA was then analyzed to ascertain inverse
relationship of production level between vif and vpr RNAs as
described above (Figure 4). As observed in Figure 12C, low
vif /Vif expressers here (NL-pSE, NL-p11807, NL-pDEMB12, and
NL-p01TT) produced higher levels (mean values) of vpr mRNA
relative to that by NL-pC3, confirming our previous results
(Nomaguchi et al., 2016).
We then performed structural (Figure 13) and stability
(Figure 14) analyses of SLSA1 derived from clones with a
naturally occurring SA1D2prox (Figure 11) as described above
(Figures 6, 7, 9, 10). Because SLSA1 sequence of three proviral
clones (NL-p04AR, NL-pEC003, and NL-pMM45) was identical
to that of NL-pC3 (Figure 11), we first predicted RNA properties
of NL-pC3 SLSA1. As shown in Figures 13, 14, the secondary
structure and free energy (dG) of NL-pC3 SLSA1 were different
from those of NL4-3 due to a G·U wobble pair and a G-C
canonical pair formed by substitution of V234gtt to L234ctt in
the stem. While SLSA1 secondary structures of NL-pDEMB12
and NL-01TT were the same with that of NL-pC3, free energies
for both structures were increased by formation of an A-U
canonical pair and A-U/C-G canonical pairs, respectively, relative
to that for NL-pC3 SLSA1. NL-pSE showed the same SLSA1
structure and free energy with those of NL4-3 SLSA1 despite
the presence of a single-nucleotide substitution. SLSA1 secondary
structures of the other three clones (NL-p11807, NL-pCu19, and
NL-pCY165) were predicted to be unique, and free energies for
the structures were different from those for predicted SLSA1
secondary structures of NL-pC3 and NL4-3.
In order to finally determine whether there is some specific
relationship between vif production and SLSA1 structure, if any,
we again created a scattered diagram by plotting vif expression
levels and SLSA1 stabilities (ddG) relative to those by NL-pC3.
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FIGURE 10 | Relationship between the vif expression level and SLSA1 RNA stability. SLSA1 variants in Figure 9 were analyzed for vif expressions and SLSA1
stabilities. Free energy (dG) for each SLSA1 RNA is predicted by mfold program (Zuker, 2003). Stability (ddG) of SLSA1 RNA structure is presented as difference of
free energy between mutants and NL4-3. For determination of vif production level, proviral clones indicated were transfected into 293T cells, and total RNA was
prepared from cells collected at 20 h post-transfection. DNase I-treated RNAs were used for cDNA synthesis with oligo (dT) primer, and resultant cDNA samples
were subjected to qRT-PCR analysis using a specific primer set for vif mRNA. Expression levels of all HIV-1 mRNA species and GAPDH mRNA were analyzed by
qRT-PCR in parallel for transfection and internal controls, respectively. A vif expression level in each sample was normalized by those of all HIV-1 mRNA species and
GAPDH mRNA. Vif expression levels relative to those by NL4-3 are presented. Mean values ± SD from three independent experiments are shown. Scatter diagram
on the right was created by plotting vif expression levels and SLSA1 stabilities [–(ddG)] of the test clones relative to those of NL4-3. Exponential trendline and
coefficient of determination (R2 = 0.084, p = 0.161 by F-test) are shown. Blue, red, and green letters indicate low, high, and excessive vif types (Nomaguchi et al.,
2016), respectively.
As seen in Figure 14, interestingly and importantly, we found
that vif production level is inversely correlated with SLSA1
stability upon examination of proviral clones with naturally
occurring full-length SA1D2prox sequences from HIV-1 strains
(R2 = 0.748). Even if data for NL-p04AR, NL-pEC003, and NL-
pMM45, which carry identical SLSA1 sequence with that of
NL-pC3, were excluded from analysis, or, relative data to those
by NL4-3, instead of those by NL-pC3, were used for analysis,
similar results (R2 = 0.732 and 0.742, respectively) were obtained.
These results are quite contrasting to those in Figures 7, 10, and
indicate that there may be a virologically significant association
between the Vif production and the SLSA1 structure.
DISCUSSION
In this study, we investigated effects of nSNVs in a genomic
SA1D2prox region on vif expression and SLSA1 structure, and
resultantly demonstrated functional importance of SA1D2prox
for modulation of vif mRNA production. Nine nSNVs that
significantly affect vif expression level (P233ccc, P233ccg,
V234gtc, K240aaa, L242ctt, A248gcg, V249gtg, N254aac, and
V259gtg) were newly found in SA1D2prox in addition to
those previously identified in SA1prox (Nomaguchi et al., 2016)
(Figures 3, 5, 7). Many of the nSNVs identified by us so far
were clustered in SLSA1 within SA1D2prox, suggesting a possible
role for SLSA1 in vif production (Figure 5). For proviral clones
carrying a single nSNV within SLSA1 and their SLSA1 structural
mutants, no clear correlation between vif expression levels and
changes in secondary structure/stability of SLSA1 was observed
(Figures 7, 10). In contrast, for proviral clones with full-length
viral genomic SA1D2prox sequences, which contain multiple
nSNVs from HIV-1 subtype B strains, a significant inverse
correlation between vif expression levels and structural stabilities
of SLSA1 RNAs was recognized (Figure 14). It has been reported
that two silent mutations introduced into HIV-1 NL4-3 SLSA1
significantly affect usage of SA1 site (Emery et al., 2017). The
observed inverse correlation between vif expression levels and
SLSA1 stabilities represents the first biological evidence to show
the functional importance of SLSA1 secondary structure, revealed
by the in vitro chemical probing approach without any cellular
components. Moreover, our findings have important implications
for elucidating the mechanisms by which SLSA1 regulates vif
expression. Vif mRNA is produced by alternative splicing of
HIV-1 pre-mRNA. In general, recognition of the splice sites by
spliceosome involves interactions between protein factors and
a single-stranded portion of the pre-mRNA (Maris et al., 2005;
Hiller et al., 2007). Interestingly, however, exon/intron junctions
that undergo alternative splicing are often thermodynamically
more stable than that of constitutive exons, indicating the
formation of RNA secondary structures (Shepard and Hertel,
2008). Such local RNA structures can interfere with spliceosomal
assembly through sterical masking of splice sites or enhancer
binding sites. Alternatively, such RNA secondary structures can
accelerate spliceosomal assembly by shielding splicing repressor
binding sites (Hertel, 2008). Present finding of inverse correlation
between SLSA1 stabilities and vif expression levels suggests that
the SLSA1 region may act for masking splice sites or enhancer
binding sites for splicing rather than the masking of repressor
binding sites. Further study to elucidate tertiary interactions
of the SA1D2prox and splicing regulators is necessary to
address this issue. Because the splicing at SD1 and SA1 sites
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FIGURE 11 | Naturally occurring full-length SA1D2prox sequences analyzed in this study. Full-length SA1D2prox sequences derived from viral strains in the HIV-1
subtype B population are shown. NL-pC3 represents a consensus sequence of SA1D2prox in HIV-1 subtype B strains. SLSA1 region and SA1/SD2 sites are
indicated. Blue and red letters show nSNVs that, upon introduction into NL4-3, phenotypically change it to the low and high vif types (Nomaguchi et al., 2016),
respectively. The nSNVs that moderately affect vif expression level are indicated by black letters (vif levels were from 0.5 to 1.2 relative to that by NL4-3). V234Lctg
site is boxed. This variation contains two and one nucleotide substitutions relative to NL4-3 and NL-pC3, respectively.
is essential for vif mRNA production, nSNVs we identified in
this study most likely affect the splicing efficiency at SA1 site.
Therefore, molecular biological analyses including experiments
to determine the splicing efficiency at SA1 site and the splicing
regulatory factors associated with the nSNVs are currently in
progress in our laboratory.
The fact that a meaningful correlation between vif expression
level and SLSA1 stability is observed only for proviral clones
carrying naturally occurring SA1D2prox is of virological
significance (Figures 11, 14). Biological and molecular bases for
emergence of such effective SA1D2prox sequences are totally
unclear at present, and remain to be clarified. Although unknown
for driving forces to generate nSNVs that affect vif mRNA
production, multiple mutations accumulated in the region over
time would benefit HIV-1 through a Vif-mediated replication
modulation. Clearly, this is not the case with proviral clones that
contain artificially constructed SA1D2prox sequences (Figures 7,
10). Given a current model that biologically relevant RNA
structures are evolutionarily retained (Jin et al., 2011), when
some mutations introduced into functionally important RNA
structures of viruses have biologically adverse effects, it is
expected that viruses carrying such mutations are eliminated
during replication cycles, or that an RNA structure critical for
viral replication is maintained by acquiring another mutation(s)
in their genomes. Thus, the introduction of an individual nSNV
into HIV-1 NL4-3 in our experiments, even if the nSNV is
found in the genomes of circulating or spreading HIV-1 strains,
would be a transient and artificial mutation for viruses, and
the change in SLSA1 structural shape/stability by the nSNV
also may not be preferable for HIV-1. On one hand, recent
structure analyses on a full-length RNA genome of HIV-1 NL4-
3 have shown that SA1D2prox sequence (excluding SLSA1)
can interact with its upstream and downstream regions (Watts
et al., 2009; Pollom et al., 2013). For naturally occurring viruses,
multiple mutations may have accumulated over time in the
entire SA1D2prox region including SLSA1, and thereby have
stabilized the whole RNA structure surrounding and containing
SA1D2prox. The nSNVs in SA1D2prox may primarily affect vif
production via various regulatory elements and factors (Figure 5)
(Kammler et al., 2006; Exline et al., 2008; Mandal et al., 2009;
Widera et al., 2013; Brillen et al., 2017). Consequently, we could
expect that the importance of SLSA1 structure and SA1D2prox
sequence for vif production became obvious only for proviral
clones carrying natural SA1D2prox sequences. In agreement
with previous reports (Pollom et al., 2013; Nomaguchi et al.,
2016), both the RNA long-range interaction and the SLSA1 local
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FIGURE 12 | Characterization of proviral clones with a naturally occurring full-length SA1D2prox sequence. Various proviral clones were examined for vif mRNA
production, Vif expression, and vpr mRNA production. (A) Expression levels of vif mRNAs by various variants. Proviral clones indicated were transfected into 293T
cells, and at 20 h post-transfection, cells were collected for extraction of total RNA. DNase I-treated total RNAs were used to synthesize cDNAs with oligo (dT)
primer, and the cDNA samples were subjected to qRT-PCR analysis using a specific primer set of vif mRNA. Expression levels of all HIV-1 mRNA species and
GAPDH mRNA were analyzed by qRT-PCR in parallel for transfection and internal controls, respectively. A vif expression level in each sample was normalized by
those of all HIV-1 mRNA species and GAPDH mRNA. Vif expression levels relative to that by NL-pC3 are presented. Blue and red bars indicate clones that exhibit
lower and higher vif expression levels, respectively, relative to that by NL-pC3. Mean values ± SD from three independent experiments are shown. All clones were
simultaneously assayed for vif production, but results obtained are separately shown for clarity. (B) Expression of Vif proteins by various variants. 293T cells were
transfected with proviral clones indicated. On day 1 post-transfection, cell lysates were prepared, and analyzed by Western blotting using anti-Vif and anti-β-actin
antibodies. Migration positions of mass standards are shown on the left. Representative data from at least two independent experiments are shown. Blue letters
indicate clones that exhibit lower vif expression level relative to that by NL-pC3. NL-p11807∗, undetectable. (C) Expression levels of vpr3 mRNA by various variants.
Semiquantitative PCR was carried out using cDNA samples prepared as described in (A) and a specific primer set for vpr mRNAs. Expression levels of all HIV-1
mRNA species and GAPDH mRNA were analyzed by semiquantitative PCR in parallel for transfection and internal controls, respectively. Signal intensities of
semiquantitative RT-PCR products were quantitated by Amersham Imager 600 instrument. Intensity of vpr3 mRNA in each sample was normalized by those of all
HIV-1 mRNA species and GAPDH mRNA. Normalized mRNA intensity in each sample relative to that by NL-pC3 is presented. Blue bars show clones with
decreased vif expression level relative to NL-pC3. Mean values ± SD from three independent experiments are shown.
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FIGURE 13 | Secondary RNA structures of SLSA1 in naturally occurring full-length SA1D2prox sequences. RNA structural shapes predicted by mfold program
(Zuker, 2003) are shown for viral clones in Figure 11.
FIGURE 14 | Relationship between vif mRNA production and SLSA1 RNA stability for clones carrying naturally occurring full-length SA1D2prox sequences. Free
energy (dG) for SLSA1 sequence derived from proviral clones indicated were predicted by mfold program (Zuker, 2003). RNA stability (ddG) is presented as
difference of free energy between NL4-3/each nSNV and NL-pC3. Relative vif expression levels to that by NL-pC3 in Figure 12 were used. Blue letters indicate
clones that gave vif expression levels significantly lower than that by NL-pC3. Scatter diagram on the right was created by plotting vif expression levels and SLSA1
stabilities [–(ddG)] of the clones relative to those of NL-pC3. Exponential trendline and coefficient of determination (R2 = 0.748, p = 0.019 by F-test) are shown.
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structure may play a key role in regulating production of HIV-1
mRNAs.
Based on result shown in Figure 14, it is likely for naturally
occurring HIV-1s that increase in SLSA1 RNA stability leads
to decrease in vif production. This interpretation indicates
that structural stabilization of SLSA1 may limit vif production.
Watts et al. (2009) reported that, while highly used splicing
acceptors are unstructured, SA1 site shows the lowest SHAPE
(selective 2′-hydroxyl acylation analyzed by primer extension)
reactivity, i.e., a stabilized secondary structure, and is a rarely
used acceptor (Purcell and Martin, 1993). Moreover, we and
others have shown that excessive Vif expression gives a negative
effect on viral replication (Akari et al., 2004; Madsen and
Stoltzfus, 2006; Exline et al., 2008; Nomaguchi et al., 2016). Thus,
stability of SLSA1 structure in addition to a nearby sequence
of SA1 site may serve to suppress surplus usage of SA1 site
critical for vif mRNA production. In this regard, it has been
reported that decrease in SA3 utilization is attributed to increased
stability of a stem-loop structure containing SA3 site in the
context of polypyrimidine tract sequence (Jacquenet et al., 2001).
This suggests that the SA3 usage is regulated not only by the
stability of the stem-loop structure but also by the sequence
of a region around SA3 site, being consistent with modulation
of vif expression by both the structural stability of SLSA1
and the SA1D2prox sequence. It has been reported that SD1
site is also included in a semistable hairpin structure (Abbink
and Berkhout, 2008). Stabilization of SD1 hairpin structure by
introducing mutations has been shown to cause severe defects
in viral replication through effects on the splicing at SD1 site
(Abbink and Berkhout, 2008). Totally, it is not unreasonable
to assume that both the SA1D2prox sequence and the stability
of SLSA1 structure influence vif production via effects on SA1
usage.
Expression levels of vif mRNA and Vif protein by nine
tested proviral clones with naturally occurring entire SA1D2prox
were not higher than those by NL4-3 and NL-pC3 (Figure 12).
Rather, some clones (NL-pSE, NL-p11807, NL-pDEMB12, and
NL-p01TT) produced reduced levels relative to NL4-3 and
NL-pC3. As described previously (Nomaguchi et al., 2016),
decrease in vif production is not always disadvantageous to HIV-
1, unless the power balance between Vif and APOBEC3G/F is
completely disrupted. Restrictive effects imposed by a sub-lethal
level of APOBEC3G/F can rather be advantageous to HIV-
1 for survival, because HIV-1 may readily acquire mutations
under such circumstances to increase genome variations. This
is beneficial for HIV-1 to adapt and evade from unfavorable
environments such as host immunity and medication (Mulder
et al., 2008; Jern et al., 2009; Sadler et al., 2010; Kim et al.,
2014). Indeed, while the growth capacity of Y226tac virus
(low vif type in Figures 7, 10) is markedly restricted in H9
cells with a high APOBEC3G expression level (Nomaguchi
et al., 2016), adapted viruses emerged from a long-term culture
of H9 cells initially infected with a high dose of this virus
clone. Sequence analysis of the adapted viruses showed that
numerous mutations are present throughout viral genomes. Of
these, a growth-enhancing mutation that moderately restores
vif expression level was identified within the Vif-coding
sequence located downstream of SA1D2prox. These results
demonstrate a high potential of HIV-1 to adapt and survive
under strictly replication-restrictive conditions (our unpublished
data). These results also indicate that vif expression level can
be modulated by sequences other than SA1D2prox. Presence of
many elements/sites involving in modulation of vif production
is suggested by the effect of GI3-1 element in the Vpr-coding
sequence on vif production, and by inverse correlation between
vif and vpr expression levels (Widera et al., 2014; Nomaguchi
et al., 2016) (Figures 4, 12). We and others have consistently
shown that viral mRNAs encoding for Vif and Vpr are expressed
in a mutually exclusive manner (Widera et al., 2014; Nomaguchi
et al., 2016). However, molecular bases for this relationship
remain elusive, and further study is needed to elucidate its
underlying mechanism.
CONCLUSION
Since Vif is an essential factor for virion infectivity, elucidating
the sequence and RNA structure relevant to the modulation of
vif production is useful to establish systems for effective control
of HIV-1 replication. Moreover, a better biological understanding
of local RNA structures and RNA long-range interactions in HIV-
1 and the other viral RNA genomes would contribute to the
progress in RNA biology.
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